The value of therapeutic drug monitoring to the practising physician- an hypothesis in need of testing.
Open Access
- 1 March 1989
- journal article
- Published by Wiley
- Vol. 27 (3) , 281-284
- https://doi.org/10.1111/j.1365-2125.1989.tb05365.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Withdrawal of Anticonvulsant Drugs in Patients Free of Seizures for Two YearsNew England Journal of Medicine, 1988
- Discontinuing Antiepileptic Medication in Children with Epilepsy after Two Years without SeizuresNew England Journal of Medicine, 1985
- Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.BMJ, 1985
- Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.BMJ, 1984
- THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITYThe Lancet, 1983
- Serum Concentration and Clinical Supervision in Monitoring of Lithium TreatmentTherapeutic Drug Monitoring, 1980
- Pharmacokinetics of digoxin: Relationship between response intensity and predicted compartmental drug levels in manJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Serum Level Monitoring and Clinical Pharmacokinetics of LithiumClinical Pharmacokinetics, 1977
- Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillationThe American Journal of Cardiology, 1975
- Measurement of Serum Digitalis Glycosides Clinical ImplicationsCirculation, 1971